The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Fulvestrant as maintenance therapy after first-line chemotherapy in postmenopausal hormone receptor-positive, HER2-negative advanced breast cancer patients (FANCY): A prospective, multicenter, single arm phase II study.
 
Shusen Wang
No Relationships to Disclose
 
Fei Xu
No Relationships to Disclose
 
Quchang Ouyang
No Relationships to Disclose
 
Zhongyu Yuan
No Relationships to Disclose
 
Danmei Pang
No Relationships to Disclose
 
Huimin Yuan
No Relationships to Disclose
 
Roujun Peng
No Relationships to Disclose
 
Wen Xia
No Relationships to Disclose
 
Qiufan Zheng
No Relationships to Disclose